RecruitingPhase 2NCT05529251
De-escalation Study for Stage IIa/IIb < 3 cm Seminoma
Studying Tumor of testis and paratestis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Centre Leon Berard
- Principal Investigator
- Aude FLECHON, DrCentre Leon Berard (Lyon, France)
- Intervention
- Radiotherapy boost(radiation)
- Enrollment
- 90 enrolled
- Eligibility
- 18 years · MALE
- Timeline
- 2022 – 2030
Study locations (15)
- CHU Besançon, Besançon, France
- CHU Bordeaux, Bordeaux, France
- Centre François Baclesse, Caen, France
- Centre Jean Perrin, Clermont-Ferrand, France
- Centre Oscar Lambret, Lille, France
- CHU de Limoges, Limoges, France
- Centre Leon Bérard, Lyon, France
- Institut Paoli Calmettes, Marseille, France
- Centre Antoine Lacassagne, Nice, France
- Hôpital Saint Louis, Paris, France
- ICO René Gauducheau, Saint-Herblain, France
- Hôpital Foch, Suresnes, France
- Institut Universitaire de Cancer de Toulouse (IUCT-O), Toulouse, France
- Institut de Cancérologie de Lorraine, Vandœuvre-lès-Nancy, France
- Institut Gustave Roussy, Villejuif, France
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05529251 on ClinicalTrials.govOther trials for Tumor of testis and paratestis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06593665Intrathecal Morphine Versus Intravenous Methadone for Postoperative Analgesia Following Retroperitoneal Lymph Node Dissection.Indiana University
- RECRUITINGPHASE2NCT06144736PRIMETEST II - Clinical Stage II A/B Seminoma Treated With RA-RPLNDHeinrich-Heine University, Duesseldorf
- RECRUITINGNCT05564026Molecular Epidemiology of Pediatric Germ Cell TumorsChildren's Oncology Group
- ACTIVE NOT RECRUITINGPHASE2NCT03937843Reduced Intensity Radio-chemotherapy for Stage IIA/B SeminomaSwiss Cancer Institute
- RECRUITINGNANCT04113122Senescence and the Early Ageing Phenotype After Chemotherapy for Testicular Cancer: the SEA-CAT StudyUniversity Medical Center Groningen
- ACTIVE NOT RECRUITINGPHASE2NCT03158064Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell TumorsMemorial Sloan Kettering Cancer Center
- ACTIVE NOT RECRUITINGNANCT01049230Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell TumorsMassachusetts General Hospital